Status:
WITHDRAWN
Depodur vs Fentanyl Infusion for Post-C/S Analgesia
Lead Sponsor:
Goodman, Evan, M.D.
Conditions:
Analgesia
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Epidurally administered Depodur provides equal or superior analgesia as an epidural infusion of fentanyl for the first 48 hours after a cesarean section.
Eligibility Criteria
Inclusion
- Healthy pregnant women (ASA I or II) who are scheduled for an elective cesarean section
- Patient appropriate for regional anesthesia
- Patient agrees to receive regional anesthesia
- Patient willing to have an epidural infusion of medication for two days postoperatively
Exclusion
- Morbid obesity
- History of sleep apnea
- Allergy to opioids medications
- History of opioids use during week prior to procedure
- Emergency cesarean section
- Significant surgical complications
- Contraindication or refusal to have regional anesthesia
- Age less than 18
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00762554
Start Date
October 1 2008
End Date
June 1 2009
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Case Medical Center
Cleveland, Ohio, United States, 44106